Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001996660 | SCV002225042 | pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2023-05-22 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PRF1 protein in which other variant(s) (p.Gln446Pro) have been determined to be pathogenic (PMID: 25326637, 26450956). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1446910). This variant has not been reported in the literature in individuals affected with PRF1-related conditions. This sequence change creates a premature translational stop signal (p.Leu189Alafs*4) in the PRF1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 367 amino acid(s) of the PRF1 protein. |
Baylor Genetics | RCV003471102 | SCV004206487 | likely pathogenic | Aplastic anemia | 2023-11-26 | criteria provided, single submitter | clinical testing |